Misconduct During IPR May Trigger an Award of Attorneys’ Fees in Related District Court Litigation

Sep 13, 2019

Reading Time : 2 min

In September 2015, plaintiff brought several district court actions against defendants alleging infringement of U.S. Patent No. 9,043,093 (the “’093 Patent”), which generally covers an airbag system for a vehicle. In response to the infringement actions, defendants filed three separate IPRs challenging every claim of the ’093 Patent. After the Patent Trial and Appeal Board instituted the first IPR, the district court stayed the infringement actions. The Board subsequently instituted the remaining IPRs and ultimately issued final written decisions finding all claims of the ’093 Patent unpatentable. After the Federal Circuit affirmed the Board’s decision in the first IPR, and denied rehearing en banc, plaintiff notified defendants that it intended to dismiss its infringement actions. Defendants then sought attorney’s fees and costs pursuant to 35 U.S.C. § 285, alleging that this was an “exceptional case.”

In deciding whether to award attorney’s fees, the court first considered plaintiff’s contention that defendants’ “exceptional case” allegations related solely to plaintiff’s conduct in the IPRs and, further, that no court had awarded attorney’s fees under Section 285 based solely on IPR conduct. In plaintiff’s view, to the extent defendants wanted to pursue sanctions for conduct during the IPRs, they should have done so before the Board, not the district court. The court, however, rejected this as a reason to deny attorney’s fees, explaining that because it ordered a stay of the infringement actions, defendants could be entitled to attorney’s fees based on the premise that the IPRs “essentially substituted” for the district court litigation. Thus, if defendants could establish that these were “exceptional cases,” they would be permitted to seek fees attributable to plaintiff’s misconduct before the Board.

After considering the strength of plaintiff’s validity positions in the IPRs and its litigation conduct, the court determined that these cases were “far more typical than exceptional” and recommended denying defendants’ request for attorney’s fees. In reaching its determination, the court rejected defendants’ argument that plaintiff’s continued pursuit of a district court case after the Board’s institution decisions made the case “exceptional.” The court also determined that defendants had failed to demonstrate any “unusual tactics of counsel or litigation misconduct,” pointing to the fact that the plaintiff voluntarily dismissed the infringement actions shortly after the Federal Circuit affirmed the Board’s decision.

Practice Tip: When litigating a post-grant proceeding at the Patent Trial and Appeal Board, parties should recognize that their conduct before the Board may be relevant to a subsequent motion for attorney’s fees in a parallel district court litigation. This is especially true where the co-pending district court case has been stayed and, therefore, the post-grant proceeding “essentially substitutes” for the district court litigation.

Am. Vehicular Sci. LLC v. Autoliv, Inc. et al., 5-16-cv-11529 (MIED 2019-08-30, Order) (Anthony P. Patti)

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.